The second version of the Prostate Imaging Reporting and Data System (PIRADSv2) is the new standard for interpreting prostate MRI. Validation studies have been performed of this scheme, but many have used targeted biopsies as the reference standard. Our validation study is unique in utilizing 3D trans-perineal mapping biopsy (3DTMB) as the reference standard. With a total of 41 MRI lesions, PI-RADSv2 score = 5 lesions had a PPV for cancer of 1.0. However, when all significant lesions (PI-RADSv2 score ≥3) were included, the PPV is 0.29, with equal PPV of PI-RADS 3 and 4 lesions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords